A team of researchers from Brigham and Women's Hospital, the University of Pittsburgh and the University of California San Diego used a single bacteriophage to treat an immunocompromised patient with ...

Researchers from the Université de Montpellier, France, and the University of Pittsburgh, have published a study (“Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant ...

Researchers at the Hebrew University of Jerusalem have identified a conserved small RNA molecule that enables bacteriophages ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 35 (September 1, 2015), pp. E4919-E4928 (10 pages) The first stages of productive bacteriophage ...

According to the WHO, antibiotic resistance is one of the biggest threats to global health, food security, and development today: "Antibiotic resistance is rising to dangerously high levels in all ...

During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented findings from the Phase IIa ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Today, Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug ...

NEW YORK--(BUSINESS WIRE)--Bioharmony Therapeutics, Inc. (“Bioharmony”), a biopharmaceutical company focusing on the development of novel therapeutics for hard to treat bacterial infections, announced ...

The Bacteriophage Market is poised for significant growth over the next decade, driven by increasing antibiotic resistance and a rising demand for alternative therapies. Innovative phage therapies are ...

Science, founded by Thomas A. Edison in 1880 and published by AAAS, today ranks as the world's largest circulation general science journal. Published 51 times a year, Science is renowned for its ...